Of 8 MTF cultured populations examined, 5 contained activating BRAF mutations (all 5 had the V600K mutation, 2 samples contained V600K and V600E mutations, and 1 also contained the V600E2 mutation (this percentage reflects the prevalence of BRAF activating mutations in cutaneous melanoma patients). Here, BRAF is linked to cutaneous melanoma.